Dutch-beta thalassemia: A rare mutation from India

Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing COVID-19 in this subset of patients. Aims: To describe the clinical manifestations of SARS-CoV2 infection in patients with TDT and to evaluate feasibility of home management for patients with mild disease. Materials and methods: The study involved TDT patients registered with thalassemia day care center, DMCH, who tested positive for COVID-19 by RTP... Mehr ...

Verfasser: Nirali Sanghvi
Priyanka Aggarwal
Vineeta Singh
Vineeta Gupta
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 74-76 (2022)
Verlag/Hrsg.: Elsevier
Schlagwörter: COVID-19 / Transfusion dependent thalassemia / Iron chelation therapy / Deferasirox / Pediatrics / RJ1-570
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28989447
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1016/j.phoj.2022.06.001